Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
3,938,449
-
Total 13F shares
-
931,843
-
Share change
-
-353,560
-
Total reported value
-
$2,683,707
-
Price per share
-
$2.88
-
Number of holders
-
16
-
Value change
-
-$1,054,952
-
Number of buys
-
5
-
Number of sells
-
8
Institutional Holders of KIORA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (KPRX) as of Q2 2025
As of 30 Jun 2025,
KIORA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (KPRX) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
931,843 shares.
The largest 10 holders included
AIGH Capital Management LLC, Nantahala Capital Management, LLC, Stonepine Capital Management, LLC, ADAR1 Capital Management, LLC, Velan Capital Investment Management LP, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., and BlackRock, Inc..
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.